nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—ALAS2—prostate gland—urinary bladder cancer	0.0108	0.0304	CbGeAlD
Glycine—Fluid overload—Carboplatin—urinary bladder cancer	0.0106	0.0695	CcSEcCtD
Glycine—GLYATL1—renal system—urinary bladder cancer	0.0104	0.0291	CbGeAlD
Glycine—AGXT—prostate gland—urinary bladder cancer	0.0098	0.0275	CbGeAlD
Glycine—GLYAT—renal system—urinary bladder cancer	0.00975	0.0273	CbGeAlD
Glycine—GCSH—prostate gland—urinary bladder cancer	0.0094	0.0263	CbGeAlD
Glycine—SHMT1—Podofilox—Etoposide—urinary bladder cancer	0.00846	1	CbGdCrCtD
Glycine—AGXT2—prostate gland—urinary bladder cancer	0.00833	0.0234	CbGeAlD
Glycine—GNMT—prostate gland—urinary bladder cancer	0.00821	0.023	CbGeAlD
Glycine—GLDC—prostate gland—urinary bladder cancer	0.00779	0.0218	CbGeAlD
Glycine—PIPOX—prostate gland—urinary bladder cancer	0.00727	0.0204	CbGeAlD
Glycine—GCAT—prostate gland—urinary bladder cancer	0.00705	0.0198	CbGeAlD
Glycine—AGXT—renal system—urinary bladder cancer	0.00668	0.0187	CbGeAlD
Glycine—GCSH—renal system—urinary bladder cancer	0.00641	0.018	CbGeAlD
Glycine—Diuresis—Cisplatin—urinary bladder cancer	0.00622	0.0409	CcSEcCtD
Glycine—ALAS1—prostate gland—urinary bladder cancer	0.00618	0.0173	CbGeAlD
Glycine—PIPOX—seminal vesicle—urinary bladder cancer	0.00615	0.0172	CbGeAlD
Glycine—GCAT—seminal vesicle—urinary bladder cancer	0.00596	0.0167	CbGeAlD
Glycine—ALAS2—female reproductive system—urinary bladder cancer	0.00592	0.0166	CbGeAlD
Glycine—Blindness transient—Methotrexate—urinary bladder cancer	0.00579	0.0381	CcSEcCtD
Glycine—AGXT2—renal system—urinary bladder cancer	0.00568	0.0159	CbGeAlD
Glycine—GARS—prostate gland—urinary bladder cancer	0.00563	0.0158	CbGeAlD
Glycine—GPR18—female reproductive system—urinary bladder cancer	0.00547	0.0153	CbGeAlD
Glycine—GLRA2—renal system—urinary bladder cancer	0.00545	0.0153	CbGeAlD
Glycine—GATM—prostate gland—urinary bladder cancer	0.00534	0.015	CbGeAlD
Glycine—GLDC—renal system—urinary bladder cancer	0.00531	0.0149	CbGeAlD
Glycine—ALAS1—seminal vesicle—urinary bladder cancer	0.00523	0.0147	CbGeAlD
Glycine—GCSH—female reproductive system—urinary bladder cancer	0.00513	0.0144	CbGeAlD
Glycine—PIPOX—renal system—urinary bladder cancer	0.00495	0.0139	CbGeAlD
Glycine—GPR18—vagina—urinary bladder cancer	0.00495	0.0139	CbGeAlD
Glycine—Urinary retention—Valrubicin—urinary bladder cancer	0.0049	0.0322	CcSEcCtD
Glycine—SHMT2—prostate gland—urinary bladder cancer	0.0049	0.0137	CbGeAlD
Glycine—PIPOX—urethra—urinary bladder cancer	0.00487	0.0136	CbGeAlD
Glycine—GARS—seminal vesicle—urinary bladder cancer	0.00476	0.0133	CbGeAlD
Glycine—GLRB—prostate gland—urinary bladder cancer	0.00459	0.0129	CbGeAlD
Glycine—AGXT2—female reproductive system—urinary bladder cancer	0.00455	0.0128	CbGeAlD
Glycine—GNMT—female reproductive system—urinary bladder cancer	0.00448	0.0126	CbGeAlD
Glycine—SHMT1—prostate gland—urinary bladder cancer	0.00446	0.0125	CbGeAlD
Glycine—GLDC—female reproductive system—urinary bladder cancer	0.00425	0.0119	CbGeAlD
Glycine—ALAS1—renal system—urinary bladder cancer	0.00421	0.0118	CbGeAlD
Glycine—ALAS1—urethra—urinary bladder cancer	0.00414	0.0116	CbGeAlD
Glycine—Thrombophlebitis—Mitomycin—urinary bladder cancer	0.0041	0.027	CcSEcCtD
Glycine—GARS—smooth muscle tissue—urinary bladder cancer	0.00399	0.0112	CbGeAlD
Glycine—GLDC—vagina—urinary bladder cancer	0.00384	0.0108	CbGeAlD
Glycine—GARS—renal system—urinary bladder cancer	0.00384	0.0108	CbGeAlD
Glycine—Encephalopathy—Thiotepa—urinary bladder cancer	0.00383	0.0252	CcSEcCtD
Glycine—SLC36A1—prostate gland—urinary bladder cancer	0.0038	0.0107	CbGeAlD
Glycine—SHMT1—seminal vesicle—urinary bladder cancer	0.00377	0.0106	CbGeAlD
Glycine—GARS—urethra—urinary bladder cancer	0.00377	0.0106	CbGeAlD
Glycine—SLC6A9—lymph node—urinary bladder cancer	0.00368	0.0103	CbGeAlD
Glycine—GATM—renal system—urinary bladder cancer	0.00364	0.0102	CbGeAlD
Glycine—PIPOX—vagina—urinary bladder cancer	0.00359	0.0101	CbGeAlD
Glycine—GCAT—vagina—urinary bladder cancer	0.00348	0.00976	CbGeAlD
Glycine—ALAS1—female reproductive system—urinary bladder cancer	0.00337	0.00946	CbGeAlD
Glycine—GSS—prostate gland—urinary bladder cancer	0.00335	0.00938	CbGeAlD
Glycine—SHMT2—renal system—urinary bladder cancer	0.00334	0.00936	CbGeAlD
Glycine—GPR18—lymph node—urinary bladder cancer	0.0032	0.00897	CbGeAlD
Glycine—Encephalopathy—Fluorouracil—urinary bladder cancer	0.00317	0.0208	CcSEcCtD
Glycine—Fluid overload—Cisplatin—urinary bladder cancer	0.0031	0.0204	CcSEcCtD
Glycine—GARS—female reproductive system—urinary bladder cancer	0.00307	0.00861	CbGeAlD
Glycine—ALAS1—vagina—urinary bladder cancer	0.00305	0.00855	CbGeAlD
Glycine—SHMT1—renal system—urinary bladder cancer	0.00304	0.00852	CbGeAlD
Glycine—Back pain—Valrubicin—urinary bladder cancer	0.003	0.0197	CcSEcCtD
Glycine—GCSH—lymph node—urinary bladder cancer	0.003	0.00841	CbGeAlD
Glycine—SHMT1—urethra—urinary bladder cancer	0.00299	0.00837	CbGeAlD
Glycine—GATM—female reproductive system—urinary bladder cancer	0.00292	0.00818	CbGeAlD
Glycine—GSS—seminal vesicle—urinary bladder cancer	0.00283	0.00794	CbGeAlD
Glycine—GARS—vagina—urinary bladder cancer	0.00278	0.00779	CbGeAlD
Glycine—SHMT2—female reproductive system—urinary bladder cancer	0.00267	0.00749	CbGeAlD
Glycine—GATM—vagina—urinary bladder cancer	0.00264	0.00739	CbGeAlD
Glycine—SLC36A1—renal system—urinary bladder cancer	0.00259	0.00726	CbGeAlD
Glycine—GLDC—lymph node—urinary bladder cancer	0.00249	0.00697	CbGeAlD
Glycine—SLC16A10—prostate gland—urinary bladder cancer	0.00245	0.00687	CbGeAlD
Glycine—SHMT1—female reproductive system—urinary bladder cancer	0.00243	0.00682	CbGeAlD
Glycine—SHMT2—vagina—urinary bladder cancer	0.00242	0.00678	CbGeAlD
Glycine—GSS—smooth muscle tissue—urinary bladder cancer	0.00237	0.00664	CbGeAlD
Glycine—GSS—renal system—urinary bladder cancer	0.00228	0.0064	CbGeAlD
Glycine—GLRB—vagina—urinary bladder cancer	0.00227	0.00635	CbGeAlD
Glycine—GCAT—lymph node—urinary bladder cancer	0.00225	0.00631	CbGeAlD
Glycine—GSS—urethra—urinary bladder cancer	0.00224	0.00628	CbGeAlD
Glycine—SHMT1—vagina—urinary bladder cancer	0.0022	0.00617	CbGeAlD
Glycine—SLC36A1—female reproductive system—urinary bladder cancer	0.00208	0.00582	CbGeAlD
Glycine—Vision blurred—Mitomycin—urinary bladder cancer	0.00202	0.0132	CcSEcCtD
Glycine—Cardiovascular disorder—Etoposide—urinary bladder cancer	0.00201	0.0132	CcSEcCtD
Glycine—Pain—Carboplatin—urinary bladder cancer	0.00201	0.0132	CcSEcCtD
Glycine—ALAS1—lymph node—urinary bladder cancer	0.00197	0.00553	CbGeAlD
Glycine—GRIN2A—vagina—urinary bladder cancer	0.00189	0.00529	CbGeAlD
Glycine—SLC36A1—vagina—urinary bladder cancer	0.00188	0.00526	CbGeAlD
Glycine—Coma—Fluorouracil—urinary bladder cancer	0.00186	0.0122	CcSEcCtD
Glycine—GSS—female reproductive system—urinary bladder cancer	0.00183	0.00512	CbGeAlD
Glycine—SLC16A10—epithelium—urinary bladder cancer	0.0018	0.00505	CbGeAlD
Glycine—GARS—lymph node—urinary bladder cancer	0.0018	0.00504	CbGeAlD
Glycine—Oedema—Mitomycin—urinary bladder cancer	0.00175	0.0115	CcSEcCtD
Glycine—Diarrhoea—Valrubicin—urinary bladder cancer	0.00173	0.0114	CcSEcCtD
Glycine—GATM—lymph node—urinary bladder cancer	0.00171	0.00478	CbGeAlD
Glycine—Thrombophlebitis—Fluorouracil—urinary bladder cancer	0.00171	0.0112	CcSEcCtD
Glycine—Urinary retention—Thiotepa—urinary bladder cancer	0.0017	0.0112	CcSEcCtD
Glycine—Dizziness—Valrubicin—urinary bladder cancer	0.00168	0.011	CcSEcCtD
Glycine—Dehydration—Thiotepa—urinary bladder cancer	0.00166	0.0109	CcSEcCtD
Glycine—GSS—vagina—urinary bladder cancer	0.00165	0.00463	CbGeAlD
Glycine—Encephalopathy—Methotrexate—urinary bladder cancer	0.00165	0.0108	CcSEcCtD
Glycine—Vomiting—Valrubicin—urinary bladder cancer	0.00161	0.0106	CcSEcCtD
Glycine—Polyuria—Cisplatin—urinary bladder cancer	0.00159	0.0105	CcSEcCtD
Glycine—SHMT2—lymph node—urinary bladder cancer	0.00156	0.00438	CbGeAlD
Glycine—Nausea—Valrubicin—urinary bladder cancer	0.0015	0.00989	CcSEcCtD
Glycine—Lung disorder—Methotrexate—urinary bladder cancer	0.0015	0.00983	CcSEcCtD
Glycine—Pain—Mitomycin—urinary bladder cancer	0.00149	0.00981	CcSEcCtD
Glycine—GLRB—lymph node—urinary bladder cancer	0.00147	0.00411	CbGeAlD
Glycine—SHMT1—lymph node—urinary bladder cancer	0.00142	0.00399	CbGeAlD
Glycine—Hyponatraemia—Cisplatin—urinary bladder cancer	0.00141	0.00924	CcSEcCtD
Glycine—Lung disorder—Epirubicin—urinary bladder cancer	0.0014	0.00919	CcSEcCtD
Glycine—SLC16A10—female reproductive system—urinary bladder cancer	0.00134	0.00375	CbGeAlD
Glycine—Dehydration—Cisplatin—urinary bladder cancer	0.0013	0.00856	CcSEcCtD
Glycine—Lung disorder—Doxorubicin—urinary bladder cancer	0.00129	0.00851	CcSEcCtD
Glycine—Angina pectoris—Fluorouracil—urinary bladder cancer	0.00124	0.00817	CcSEcCtD
Glycine—SLC36A1—lymph node—urinary bladder cancer	0.00121	0.0034	CbGeAlD
Glycine—SLC16A10—vagina—urinary bladder cancer	0.00121	0.00339	CbGeAlD
Glycine—Diarrhoea—Mitomycin—urinary bladder cancer	0.00119	0.00785	CcSEcCtD
Glycine—Dizziness—Mitomycin—urinary bladder cancer	0.00115	0.00758	CcSEcCtD
Glycine—Cardiovascular disorder—Epirubicin—urinary bladder cancer	0.00113	0.00741	CcSEcCtD
Glycine—Vomiting—Mitomycin—urinary bladder cancer	0.00111	0.00729	CcSEcCtD
Glycine—Chills—Thiotepa—urinary bladder cancer	0.00111	0.00728	CcSEcCtD
Glycine—GSS—lymph node—urinary bladder cancer	0.00107	0.003	CbGeAlD
Glycine—Cardiovascular disorder—Doxorubicin—urinary bladder cancer	0.00104	0.00685	CcSEcCtD
Glycine—Rhinitis—Gemcitabine—urinary bladder cancer	0.00104	0.00684	CcSEcCtD
Glycine—Back pain—Thiotepa—urinary bladder cancer	0.00104	0.00683	CcSEcCtD
Glycine—Nausea—Mitomycin—urinary bladder cancer	0.00104	0.00681	CcSEcCtD
Glycine—Rhinitis—Fluorouracil—urinary bladder cancer	0.00102	0.00673	CcSEcCtD
Glycine—Vision blurred—Thiotepa—urinary bladder cancer	0.00101	0.00666	CcSEcCtD
Glycine—Coma—Methotrexate—urinary bladder cancer	0.000967	0.00635	CcSEcCtD
Glycine—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.000962	0.00632	CcSEcCtD
Glycine—Visual impairment—Cisplatin—urinary bladder cancer	0.000933	0.00613	CcSEcCtD
Glycine—Chills—Gemcitabine—urinary bladder cancer	0.000932	0.00613	CcSEcCtD
Glycine—Convulsion—Thiotepa—urinary bladder cancer	0.000932	0.00612	CcSEcCtD
Glycine—Coma—Epirubicin—urinary bladder cancer	0.000905	0.00595	CcSEcCtD
Glycine—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.00089	0.00585	CcSEcCtD
Glycine—Thrombophlebitis—Methotrexate—urinary bladder cancer	0.000888	0.00583	CcSEcCtD
Glycine—Back pain—Gemcitabine—urinary bladder cancer	0.000875	0.00575	CcSEcCtD
Glycine—Polyuria—Methotrexate—urinary bladder cancer	0.000875	0.00575	CcSEcCtD
Glycine—Tachycardia—Thiotepa—urinary bladder cancer	0.000857	0.00563	CcSEcCtD
Glycine—Vision blurred—Fluorouracil—urinary bladder cancer	0.000838	0.00551	CcSEcCtD
Glycine—Coma—Doxorubicin—urinary bladder cancer	0.000837	0.0055	CcSEcCtD
Glycine—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.000831	0.00546	CcSEcCtD
Glycine—Visual disturbance—Methotrexate—urinary bladder cancer	0.000811	0.00533	CcSEcCtD
Glycine—Chills—Etoposide—urinary bladder cancer	0.000796	0.00523	CcSEcCtD
Glycine—Vision blurred—Cisplatin—urinary bladder cancer	0.000795	0.00522	CcSEcCtD
Glycine—SLC16A10—lymph node—urinary bladder cancer	0.000783	0.00219	CbGeAlD
Glycine—Convulsion—Fluorouracil—urinary bladder cancer	0.000771	0.00506	CcSEcCtD
Glycine—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.000768	0.00505	CcSEcCtD
Glycine—Pain—Thiotepa—urinary bladder cancer	0.00075	0.00493	CcSEcCtD
Glycine—Back pain—Etoposide—urinary bladder cancer	0.000747	0.00491	CcSEcCtD
Glycine—Oedema—Gemcitabine—urinary bladder cancer	0.000738	0.00485	CcSEcCtD
Glycine—Convulsion—Cisplatin—urinary bladder cancer	0.000731	0.0048	CcSEcCtD
Glycine—Oedema—Fluorouracil—urinary bladder cancer	0.000726	0.00477	CcSEcCtD
Glycine—Hyponatraemia—Epirubicin—urinary bladder cancer	0.000722	0.00474	CcSEcCtD
Glycine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000708	0.00465	CcSEcCtD
Glycine—Urticaria—Thiotepa—urinary bladder cancer	0.000697	0.00458	CcSEcCtD
Glycine—Vertigo—Etoposide—urinary bladder cancer	0.000694	0.00456	CcSEcCtD
Glycine—Hypotension—Gemcitabine—urinary bladder cancer	0.00069	0.00453	CcSEcCtD
Glycine—Oedema—Cisplatin—urinary bladder cancer	0.000688	0.00452	CcSEcCtD
Glycine—Hypotension—Fluorouracil—urinary bladder cancer	0.000678	0.00446	CcSEcCtD
Glycine—Tachycardia—Cisplatin—urinary bladder cancer	0.000672	0.00441	CcSEcCtD
Glycine—Convulsion—Etoposide—urinary bladder cancer	0.000669	0.0044	CcSEcCtD
Glycine—Dehydration—Epirubicin—urinary bladder cancer	0.000669	0.00439	CcSEcCtD
Glycine—Hyponatraemia—Doxorubicin—urinary bladder cancer	0.000668	0.00439	CcSEcCtD
Glycine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000647	0.00425	CcSEcCtD
Glycine—Hypotension—Cisplatin—urinary bladder cancer	0.000643	0.00422	CcSEcCtD
Glycine—Pain—Gemcitabine—urinary bladder cancer	0.000631	0.00415	CcSEcCtD
Glycine—Pain—Fluorouracil—urinary bladder cancer	0.000621	0.00408	CcSEcCtD
Glycine—Dehydration—Doxorubicin—urinary bladder cancer	0.000619	0.00407	CcSEcCtD
Glycine—Tachycardia—Etoposide—urinary bladder cancer	0.000615	0.00404	CcSEcCtD
Glycine—Angina pectoris—Epirubicin—urinary bladder cancer	0.000605	0.00398	CcSEcCtD
Glycine—Diarrhoea—Thiotepa—urinary bladder cancer	0.0006	0.00395	CcSEcCtD
Glycine—Hypotension—Etoposide—urinary bladder cancer	0.000589	0.00387	CcSEcCtD
Glycine—Pain—Cisplatin—urinary bladder cancer	0.000588	0.00387	CcSEcCtD
Glycine—Dizziness—Thiotepa—urinary bladder cancer	0.00058	0.00381	CcSEcCtD
Glycine—Urticaria—Fluorouracil—urinary bladder cancer	0.000577	0.00379	CcSEcCtD
Glycine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.00056	0.00368	CcSEcCtD
Glycine—Vomiting—Thiotepa—urinary bladder cancer	0.000558	0.00367	CcSEcCtD
Glycine—Pain—Etoposide—urinary bladder cancer	0.000539	0.00354	CcSEcCtD
Glycine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000535	0.00351	CcSEcCtD
Glycine—Nausea—Thiotepa—urinary bladder cancer	0.000521	0.00343	CcSEcCtD
Glycine—Visual impairment—Methotrexate—urinary bladder cancer	0.000512	0.00337	CcSEcCtD
Glycine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000507	0.00333	CcSEcCtD
Glycine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000505	0.00332	CcSEcCtD
Glycine—Urticaria—Etoposide—urinary bladder cancer	0.000501	0.00329	CcSEcCtD
Glycine—Rhinitis—Epirubicin—urinary bladder cancer	0.000499	0.00328	CcSEcCtD
Glycine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000497	0.00326	CcSEcCtD
Glycine—Dizziness—Fluorouracil—urinary bladder cancer	0.00048	0.00315	CcSEcCtD
Glycine—Visual impairment—Epirubicin—urinary bladder cancer	0.000479	0.00315	CcSEcCtD
Glycine—Chills—Methotrexate—urinary bladder cancer	0.000477	0.00313	CcSEcCtD
Glycine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000471	0.00309	CcSEcCtD
Glycine—Vomiting—Gemcitabine—urinary bladder cancer	0.000469	0.00308	CcSEcCtD
Glycine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000464	0.00305	CcSEcCtD
Glycine—Vomiting—Fluorouracil—urinary bladder cancer	0.000462	0.00303	CcSEcCtD
Glycine—Rhinitis—Doxorubicin—urinary bladder cancer	0.000461	0.00303	CcSEcCtD
Glycine—Back pain—Methotrexate—urinary bladder cancer	0.000448	0.00294	CcSEcCtD
Glycine—Chills—Epirubicin—urinary bladder cancer	0.000446	0.00293	CcSEcCtD
Glycine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000444	0.00291	CcSEcCtD
Glycine—Nausea—Gemcitabine—urinary bladder cancer	0.000439	0.00288	CcSEcCtD
Glycine—Vomiting—Cisplatin—urinary bladder cancer	0.000438	0.00287	CcSEcCtD
Glycine—Vision blurred—Methotrexate—urinary bladder cancer	0.000436	0.00287	CcSEcCtD
Glycine—Diarrhoea—Etoposide—urinary bladder cancer	0.000431	0.00283	CcSEcCtD
Glycine—Nausea—Fluorouracil—urinary bladder cancer	0.000431	0.00283	CcSEcCtD
Glycine—Back pain—Epirubicin—urinary bladder cancer	0.000419	0.00275	CcSEcCtD
Glycine—Dizziness—Etoposide—urinary bladder cancer	0.000417	0.00274	CcSEcCtD
Glycine—Vertigo—Methotrexate—urinary bladder cancer	0.000416	0.00273	CcSEcCtD
Glycine—Chills—Doxorubicin—urinary bladder cancer	0.000413	0.00271	CcSEcCtD
Glycine—Nausea—Cisplatin—urinary bladder cancer	0.000409	0.00269	CcSEcCtD
Glycine—Vision blurred—Epirubicin—urinary bladder cancer	0.000408	0.00268	CcSEcCtD
Glycine—Convulsion—Methotrexate—urinary bladder cancer	0.000401	0.00263	CcSEcCtD
Glycine—Vomiting—Etoposide—urinary bladder cancer	0.000401	0.00263	CcSEcCtD
Glycine—Vertigo—Epirubicin—urinary bladder cancer	0.000389	0.00256	CcSEcCtD
Glycine—Back pain—Doxorubicin—urinary bladder cancer	0.000388	0.00255	CcSEcCtD
Glycine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000378	0.00248	CcSEcCtD
Glycine—Convulsion—Epirubicin—urinary bladder cancer	0.000375	0.00246	CcSEcCtD
Glycine—Nausea—Etoposide—urinary bladder cancer	0.000374	0.00246	CcSEcCtD
Glycine—Vertigo—Doxorubicin—urinary bladder cancer	0.00036	0.00237	CcSEcCtD
Glycine—Oedema—Epirubicin—urinary bladder cancer	0.000353	0.00232	CcSEcCtD
Glycine—Hypotension—Methotrexate—urinary bladder cancer	0.000353	0.00232	CcSEcCtD
Glycine—Convulsion—Doxorubicin—urinary bladder cancer	0.000347	0.00228	CcSEcCtD
Glycine—Tachycardia—Epirubicin—urinary bladder cancer	0.000345	0.00227	CcSEcCtD
Glycine—Hypotension—Epirubicin—urinary bladder cancer	0.00033	0.00217	CcSEcCtD
Glycine—Oedema—Doxorubicin—urinary bladder cancer	0.000327	0.00215	CcSEcCtD
Glycine—Pain—Methotrexate—urinary bladder cancer	0.000323	0.00212	CcSEcCtD
Glycine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000319	0.0021	CcSEcCtD
Glycine—Hypotension—Doxorubicin—urinary bladder cancer	0.000306	0.00201	CcSEcCtD
Glycine—Pain—Epirubicin—urinary bladder cancer	0.000302	0.00199	CcSEcCtD
Glycine—Urticaria—Methotrexate—urinary bladder cancer	0.0003	0.00197	CcSEcCtD
Glycine—Urticaria—Epirubicin—urinary bladder cancer	0.000281	0.00184	CcSEcCtD
Glycine—Pain—Doxorubicin—urinary bladder cancer	0.00028	0.00184	CcSEcCtD
Glycine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000278	0.00183	CcSEcCtD
Glycine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00026	0.00171	CcSEcCtD
Glycine—Urticaria—Doxorubicin—urinary bladder cancer	0.00026	0.00171	CcSEcCtD
Glycine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000258	0.0017	CcSEcCtD
Glycine—Dizziness—Methotrexate—urinary bladder cancer	0.00025	0.00164	CcSEcCtD
Glycine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000242	0.00159	CcSEcCtD
Glycine—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000241	0.00158	CcSEcCtD
Glycine—Vomiting—Methotrexate—urinary bladder cancer	0.00024	0.00158	CcSEcCtD
Glycine—Dizziness—Epirubicin—urinary bladder cancer	0.000234	0.00154	CcSEcCtD
Glycine—Vomiting—Epirubicin—urinary bladder cancer	0.000225	0.00148	CcSEcCtD
Glycine—Nausea—Methotrexate—urinary bladder cancer	0.000224	0.00147	CcSEcCtD
Glycine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000224	0.00147	CcSEcCtD
Glycine—Dizziness—Doxorubicin—urinary bladder cancer	0.000216	0.00142	CcSEcCtD
Glycine—Nausea—Epirubicin—urinary bladder cancer	0.00021	0.00138	CcSEcCtD
Glycine—Vomiting—Doxorubicin—urinary bladder cancer	0.000208	0.00137	CcSEcCtD
Glycine—Nausea—Doxorubicin—urinary bladder cancer	0.000194	0.00128	CcSEcCtD
Glycine—BAAT—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000166	0.000343	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—TNF—urinary bladder cancer	0.000164	0.000341	CbGpPWpGaD
Glycine—AGXT2—Metabolism—NAT2—urinary bladder cancer	0.000164	0.000341	CbGpPWpGaD
Glycine—ALAS1—Metabolism—RRM2—urinary bladder cancer	0.000162	0.000335	CbGpPWpGaD
Glycine—ALAS2—Metabolism—GSTP1—urinary bladder cancer	0.000161	0.000334	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000157	0.000326	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000157	0.000326	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000157	0.000326	CbGpPWpGaD
Glycine—AGXT—Metabolism—ENO2—urinary bladder cancer	0.000155	0.00032	CbGpPWpGaD
Glycine—AGXT—Metabolism—HPGDS—urinary bladder cancer	0.000155	0.00032	CbGpPWpGaD
Glycine—ALAS2—Metabolism—TYMS—urinary bladder cancer	0.00015	0.000311	CbGpPWpGaD
Glycine—AGXT—Metabolism—GSTT1—urinary bladder cancer	0.00015	0.000311	CbGpPWpGaD
Glycine—GARS—Gene Expression—ESR1—urinary bladder cancer	0.00015	0.00031	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ENO2—urinary bladder cancer	0.00015	0.00031	CbGpPWpGaD
Glycine—ALAS1—Metabolism—HPGDS—urinary bladder cancer	0.00015	0.00031	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000149	0.000308	CbGpPWpGaD
Glycine—ALAS2—Metabolism—GSTM1—urinary bladder cancer	0.000148	0.000307	CbGpPWpGaD
Glycine—SHMT1—Metabolism—TYMP—urinary bladder cancer	0.000148	0.000307	CbGpPWpGaD
Glycine—ALAS2—Metabolism—NCOR1—urinary bladder cancer	0.000148	0.000307	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—NQO1—urinary bladder cancer	0.000146	0.000304	CbGpPWpGaD
Glycine—GLYAT—Metabolism—NQO1—urinary bladder cancer	0.000146	0.000304	CbGpPWpGaD
Glycine—GATM—Metabolism—NQO1—urinary bladder cancer	0.000146	0.000304	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—NQO1—urinary bladder cancer	0.000146	0.000304	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GSTT1—urinary bladder cancer	0.000145	0.000301	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—TP53—urinary bladder cancer	0.000145	0.0003	CbGpPWpGaD
Glycine—GSS—Metabolism—TYMP—urinary bladder cancer	0.000144	0.000299	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RBX1—urinary bladder cancer	0.000144	0.000299	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000143	0.000296	CbGpPWpGaD
Glycine—ALAS2—Metabolism—GPX1—urinary bladder cancer	0.000142	0.000294	CbGpPWpGaD
Glycine—AGXT2—Metabolism—RRM2—urinary bladder cancer	0.000142	0.000294	CbGpPWpGaD
Glycine—BAAT—Metabolism—NQO1—urinary bladder cancer	0.00014	0.00029	CbGpPWpGaD
Glycine—ALAS2—Metabolism—ERCC2—urinary bladder cancer	0.000139	0.000289	CbGpPWpGaD
Glycine—GARS—Gene Expression—PPARG—urinary bladder cancer	0.000137	0.000283	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—HRAS—urinary bladder cancer	0.000136	0.000283	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000136	0.000281	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TSC1—urinary bladder cancer	0.000135	0.000281	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NAT2—urinary bladder cancer	0.000134	0.000278	CbGpPWpGaD
Glycine—AGXT2—Metabolism—HPGDS—urinary bladder cancer	0.000131	0.000272	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ENO2—urinary bladder cancer	0.000131	0.000272	CbGpPWpGaD
Glycine—GARS—Gene Expression—CREBBP—urinary bladder cancer	0.000131	0.000272	CbGpPWpGaD
Glycine—ALAS2—Metabolism—MTHFR—urinary bladder cancer	0.000131	0.000271	CbGpPWpGaD
Glycine—GSS—Metabolism—NAT2—urinary bladder cancer	0.000131	0.000271	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—JAG1—urinary bladder cancer	0.000129	0.000267	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000128	0.000266	CbGpPWpGaD
Glycine—SHMT1—Disease—ENO2—urinary bladder cancer	0.000128	0.000265	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTT1—urinary bladder cancer	0.000127	0.000264	CbGpPWpGaD
Glycine—AGXT—Metabolism—NQO1—urinary bladder cancer	0.000125	0.000258	CbGpPWpGaD
Glycine—GLYAT—Metabolism—GSTP1—urinary bladder cancer	0.000122	0.000253	CbGpPWpGaD
Glycine—GATM—Metabolism—GSTP1—urinary bladder cancer	0.000122	0.000253	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—GSTP1—urinary bladder cancer	0.000122	0.000253	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—GSTP1—urinary bladder cancer	0.000122	0.000253	CbGpPWpGaD
Glycine—SHMT1—Disease—RBX1—urinary bladder cancer	0.000121	0.000251	CbGpPWpGaD
Glycine—ALAS1—Metabolism—NQO1—urinary bladder cancer	0.000121	0.00025	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000118	0.000245	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000117	0.000243	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000117	0.000243	CbGpPWpGaD
Glycine—BAAT—Metabolism—GSTP1—urinary bladder cancer	0.000117	0.000242	CbGpPWpGaD
Glycine—SHMT1—Metabolism—RRM2—urinary bladder cancer	0.000116	0.00024	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	0.000115	0.000238	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—TYMS—urinary bladder cancer	0.000114	0.000235	CbGpPWpGaD
Glycine—GATM—Metabolism—TYMS—urinary bladder cancer	0.000114	0.000235	CbGpPWpGaD
Glycine—GLYAT—Metabolism—TYMS—urinary bladder cancer	0.000114	0.000235	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—TYMS—urinary bladder cancer	0.000114	0.000235	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000113	0.000234	CbGpPWpGaD
Glycine—GSS—Metabolism—RRM2—urinary bladder cancer	0.000113	0.000234	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—NCOR1—urinary bladder cancer	0.000112	0.000233	CbGpPWpGaD
Glycine—GATM—Metabolism—GSTM1—urinary bladder cancer	0.000112	0.000233	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—GSTM1—urinary bladder cancer	0.000112	0.000233	CbGpPWpGaD
Glycine—GATM—Metabolism—NCOR1—urinary bladder cancer	0.000112	0.000233	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—NCOR1—urinary bladder cancer	0.000112	0.000233	CbGpPWpGaD
Glycine—GLYAT—Metabolism—GSTM1—urinary bladder cancer	0.000112	0.000233	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—GSTM1—urinary bladder cancer	0.000112	0.000233	CbGpPWpGaD
Glycine—GLYAT—Metabolism—NCOR1—urinary bladder cancer	0.000112	0.000233	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—RHOA—urinary bladder cancer	0.000109	0.000226	CbGpPWpGaD
Glycine—SHMT1—Disease—JAG1—urinary bladder cancer	0.000109	0.000225	CbGpPWpGaD
Glycine—BAAT—Metabolism—TYMS—urinary bladder cancer	0.000108	0.000225	CbGpPWpGaD
Glycine—GATM—Metabolism—GPX1—urinary bladder cancer	0.000108	0.000223	CbGpPWpGaD
Glycine—GLYAT—Metabolism—GPX1—urinary bladder cancer	0.000108	0.000223	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—GPX1—urinary bladder cancer	0.000108	0.000223	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—GPX1—urinary bladder cancer	0.000108	0.000223	CbGpPWpGaD
Glycine—SHMT1—Metabolism—HPGDS—urinary bladder cancer	0.000107	0.000222	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ENO2—urinary bladder cancer	0.000107	0.000222	CbGpPWpGaD
Glycine—BAAT—Metabolism—GSTM1—urinary bladder cancer	0.000107	0.000222	CbGpPWpGaD
Glycine—BAAT—Metabolism—NCOR1—urinary bladder cancer	0.000107	0.000222	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PPARG—urinary bladder cancer	0.000106	0.00022	CbGpPWpGaD
Glycine—AGXT2—Metabolism—NQO1—urinary bladder cancer	0.000106	0.000219	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ERCC2—urinary bladder cancer	0.000106	0.000219	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ERCC2—urinary bladder cancer	0.000106	0.000219	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ERCC2—urinary bladder cancer	0.000106	0.000219	CbGpPWpGaD
Glycine—GATM—Metabolism—ERCC2—urinary bladder cancer	0.000106	0.000219	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—S100B—urinary bladder cancer	0.000104	0.000216	CbGpPWpGaD
Glycine—GSS—Metabolism—ENO2—urinary bladder cancer	0.000104	0.000216	CbGpPWpGaD
Glycine—GSS—Metabolism—HPGDS—urinary bladder cancer	0.000104	0.000216	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTT1—urinary bladder cancer	0.000104	0.000215	CbGpPWpGaD
Glycine—AGXT—Metabolism—GSTP1—urinary bladder cancer	0.000104	0.000215	CbGpPWpGaD
Glycine—BAAT—Metabolism—GPX1—urinary bladder cancer	0.000103	0.000213	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000102	0.000212	CbGpPWpGaD
Glycine—ALAS2—Metabolism—CREBBP—urinary bladder cancer	0.000102	0.000211	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.000101	0.00021	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTT1—urinary bladder cancer	0.000101	0.00021	CbGpPWpGaD
Glycine—BAAT—Metabolism—ERCC2—urinary bladder cancer	0.000101	0.000209	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GSTP1—urinary bladder cancer	0.000101	0.000208	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—MTHFR—urinary bladder cancer	9.92e-05	0.000206	CbGpPWpGaD
Glycine—GLYAT—Metabolism—MTHFR—urinary bladder cancer	9.92e-05	0.000206	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—MTHFR—urinary bladder cancer	9.92e-05	0.000206	CbGpPWpGaD
Glycine—GATM—Metabolism—MTHFR—urinary bladder cancer	9.92e-05	0.000206	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—RHOA—urinary bladder cancer	9.9e-05	0.000205	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.73e-05	0.000202	CbGpPWpGaD
Glycine—AGXT—Metabolism—TYMS—urinary bladder cancer	9.66e-05	0.0002	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CXCL8—urinary bladder cancer	9.57e-05	0.000198	CbGpPWpGaD
Glycine—AGXT—Metabolism—GSTM1—urinary bladder cancer	9.55e-05	0.000198	CbGpPWpGaD
Glycine—AGXT—Metabolism—NCOR1—urinary bladder cancer	9.55e-05	0.000198	CbGpPWpGaD
Glycine—BAAT—Metabolism—MTHFR—urinary bladder cancer	9.46e-05	0.000196	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NCOR1—urinary bladder cancer	9.39e-05	0.000195	CbGpPWpGaD
Glycine—ALAS1—Metabolism—TYMS—urinary bladder cancer	9.35e-05	0.000194	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GSTM1—urinary bladder cancer	9.24e-05	0.000192	CbGpPWpGaD
Glycine—ALAS1—Metabolism—NCOR1—urinary bladder cancer	9.24e-05	0.000192	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—IL2—urinary bladder cancer	9.14e-05	0.000189	CbGpPWpGaD
Glycine—AGXT—Metabolism—GPX1—urinary bladder cancer	9.14e-05	0.000189	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.04e-05	0.000187	CbGpPWpGaD
Glycine—AGXT—Metabolism—ERCC2—urinary bladder cancer	8.97e-05	0.000186	CbGpPWpGaD
Glycine—ALAS1—Metabolism—GPX1—urinary bladder cancer	8.85e-05	0.000183	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTP1—urinary bladder cancer	8.83e-05	0.000183	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	8.77e-05	0.000182	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ERCC2—urinary bladder cancer	8.69e-05	0.00018	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CXCL8—urinary bladder cancer	8.69e-05	0.00018	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	8.63e-05	0.000179	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NQO1—urinary bladder cancer	8.63e-05	0.000179	CbGpPWpGaD
Glycine—AGXT—Metabolism—MTHFR—urinary bladder cancer	8.44e-05	0.000175	CbGpPWpGaD
Glycine—GSS—Metabolism—NQO1—urinary bladder cancer	8.41e-05	0.000174	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTGS2—urinary bladder cancer	8.35e-05	0.000173	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL2—urinary bladder cancer	8.3e-05	0.000172	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TERT—urinary bladder cancer	8.27e-05	0.000171	CbGpPWpGaD
Glycine—AGXT2—Metabolism—TYMS—urinary bladder cancer	8.21e-05	0.00017	CbGpPWpGaD
Glycine—ALAS1—Metabolism—MTHFR—urinary bladder cancer	8.17e-05	0.000169	CbGpPWpGaD
Glycine—AGXT2—Metabolism—NCOR1—urinary bladder cancer	8.12e-05	0.000168	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GSTM1—urinary bladder cancer	8.12e-05	0.000168	CbGpPWpGaD
Glycine—GATM—Metabolism—PPARG—urinary bladder cancer	8.05e-05	0.000167	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PPARG—urinary bladder cancer	8.05e-05	0.000167	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PPARG—urinary bladder cancer	8.05e-05	0.000167	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PPARG—urinary bladder cancer	8.05e-05	0.000167	CbGpPWpGaD
Glycine—SHMT1—Disease—NCOR1—urinary bladder cancer	7.9e-05	0.000164	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—urinary bladder cancer	7.78e-05	0.000161	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GPX1—urinary bladder cancer	7.77e-05	0.000161	CbGpPWpGaD
Glycine—GATM—Metabolism—CREBBP—urinary bladder cancer	7.73e-05	0.00016	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CREBBP—urinary bladder cancer	7.73e-05	0.00016	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CREBBP—urinary bladder cancer	7.73e-05	0.00016	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CREBBP—urinary bladder cancer	7.73e-05	0.00016	CbGpPWpGaD
Glycine—BAAT—Metabolism—PPARG—urinary bladder cancer	7.67e-05	0.000159	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ERCC2—urinary bladder cancer	7.63e-05	0.000158	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—FGFR3—urinary bladder cancer	7.59e-05	0.000157	CbGpPWpGaD
Glycine—SHMT1—Disease—ERCC2—urinary bladder cancer	7.43e-05	0.000154	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ESR1—urinary bladder cancer	7.37e-05	0.000153	CbGpPWpGaD
Glycine—BAAT—Metabolism—CREBBP—urinary bladder cancer	7.37e-05	0.000153	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PTEN—urinary bladder cancer	7.28e-05	0.000151	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTP1—urinary bladder cancer	7.2e-05	0.000149	CbGpPWpGaD
Glycine—AGXT2—Metabolism—MTHFR—urinary bladder cancer	7.17e-05	0.000149	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTP1—urinary bladder cancer	7.02e-05	0.000145	CbGpPWpGaD
Glycine—SHMT1—Disease—MTHFR—urinary bladder cancer	6.98e-05	0.000145	CbGpPWpGaD
Glycine—SHMT1—Disease—TERT—urinary bladder cancer	6.96e-05	0.000144	CbGpPWpGaD
Glycine—ALAS2—Metabolism—EP300—urinary bladder cancer	6.95e-05	0.000144	CbGpPWpGaD
Glycine—AGXT—Metabolism—PPARG—urinary bladder cancer	6.84e-05	0.000142	CbGpPWpGaD
Glycine—SHMT1—Metabolism—TYMS—urinary bladder cancer	6.69e-05	0.000139	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPARG—urinary bladder cancer	6.63e-05	0.000137	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GSTM1—urinary bladder cancer	6.62e-05	0.000137	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NCOR1—urinary bladder cancer	6.62e-05	0.000137	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—HRAS—urinary bladder cancer	6.62e-05	0.000137	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	6.59e-05	0.000137	CbGpPWpGaD
Glycine—AGXT—Metabolism—CREBBP—urinary bladder cancer	6.57e-05	0.000136	CbGpPWpGaD
Glycine—GSS—Metabolism—TYMS—urinary bladder cancer	6.52e-05	0.000135	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CREBBP—urinary bladder cancer	6.46e-05	0.000134	CbGpPWpGaD
Glycine—GSS—Metabolism—NCOR1—urinary bladder cancer	6.45e-05	0.000134	CbGpPWpGaD
Glycine—GSS—Metabolism—GSTM1—urinary bladder cancer	6.45e-05	0.000134	CbGpPWpGaD
Glycine—SHMT1—Disease—FGFR3—urinary bladder cancer	6.39e-05	0.000132	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IGF1—urinary bladder cancer	6.38e-05	0.000132	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CREBBP—urinary bladder cancer	6.36e-05	0.000132	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—EGFR—urinary bladder cancer	6.35e-05	0.000132	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GPX1—urinary bladder cancer	6.34e-05	0.000131	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTGS2—urinary bladder cancer	6.33e-05	0.000131	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTGS2—urinary bladder cancer	6.33e-05	0.000131	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTGS2—urinary bladder cancer	6.33e-05	0.000131	CbGpPWpGaD
Glycine—GATM—Metabolism—PTGS2—urinary bladder cancer	6.33e-05	0.000131	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ERCC2—urinary bladder cancer	6.22e-05	0.000129	CbGpPWpGaD
Glycine—GSS—Metabolism—GPX1—urinary bladder cancer	6.17e-05	0.000128	CbGpPWpGaD
Glycine—GSS—Metabolism—ERCC2—urinary bladder cancer	6.06e-05	0.000126	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTGS2—urinary bladder cancer	6.04e-05	0.000125	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—KRAS—urinary bladder cancer	6e-05	0.000124	CbGpPWpGaD
Glycine—SHMT1—Metabolism—MTHFR—urinary bladder cancer	5.85e-05	0.000121	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RHOA—urinary bladder cancer	5.85e-05	0.000121	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPARG—urinary bladder cancer	5.82e-05	0.000121	CbGpPWpGaD
Glycine—GSS—Metabolism—MTHFR—urinary bladder cancer	5.7e-05	0.000118	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CREBBP—urinary bladder cancer	5.59e-05	0.000116	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTEN—urinary bladder cancer	5.52e-05	0.000114	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTEN—urinary bladder cancer	5.52e-05	0.000114	CbGpPWpGaD
Glycine—GATM—Metabolism—PTEN—urinary bladder cancer	5.52e-05	0.000114	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTEN—urinary bladder cancer	5.52e-05	0.000114	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	5.5e-05	0.000114	CbGpPWpGaD
Glycine—SHMT1—Disease—CREBBP—urinary bladder cancer	5.44e-05	0.000113	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ERBB2—urinary bladder cancer	5.41e-05	0.000112	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS2—urinary bladder cancer	5.38e-05	0.000112	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTEN—urinary bladder cancer	5.27e-05	0.000109	CbGpPWpGaD
Glycine—GATM—Metabolism—EP300—urinary bladder cancer	5.26e-05	0.000109	CbGpPWpGaD
Glycine—GLYAT—Metabolism—EP300—urinary bladder cancer	5.26e-05	0.000109	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—EP300—urinary bladder cancer	5.26e-05	0.000109	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—EP300—urinary bladder cancer	5.26e-05	0.000109	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS2—urinary bladder cancer	5.21e-05	0.000108	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL8—urinary bladder cancer	5.13e-05	0.000106	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HRAS—urinary bladder cancer	5.1e-05	0.000106	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—HRAS—urinary bladder cancer	5.05e-05	0.000105	CbGpPWpGaD
Glycine—BAAT—Metabolism—EP300—urinary bladder cancer	5.02e-05	0.000104	CbGpPWpGaD
Glycine—SHMT1—Disease—RHOA—urinary bladder cancer	4.92e-05	0.000102	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—urinary bladder cancer	4.9e-05	0.000102	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCND1—urinary bladder cancer	4.78e-05	9.91e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARG—urinary bladder cancer	4.74e-05	9.83e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTEN—urinary bladder cancer	4.69e-05	9.73e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MMP9—urinary bladder cancer	4.64e-05	9.62e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CDKN1A—urinary bladder cancer	4.63e-05	9.59e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARG—urinary bladder cancer	4.62e-05	9.58e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PTEN—urinary bladder cancer	4.62e-05	9.56e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS2—urinary bladder cancer	4.58e-05	9.48e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CREBBP—urinary bladder cancer	4.55e-05	9.44e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—ERBB2—urinary bladder cancer	4.55e-05	9.44e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTEN—urinary bladder cancer	4.55e-05	9.42e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—EP300—urinary bladder cancer	4.48e-05	9.28e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTGS2—urinary bladder cancer	4.45e-05	9.23e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CREBBP—urinary bladder cancer	4.44e-05	9.2e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EP300—urinary bladder cancer	4.4e-05	9.12e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—EP300—urinary bladder cancer	4.33e-05	8.98e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SRC—urinary bladder cancer	4.28e-05	8.87e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTEN—urinary bladder cancer	3.99e-05	8.27e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CDKN1A—urinary bladder cancer	3.89e-05	8.07e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTEN—urinary bladder cancer	3.88e-05	8.05e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—urinary bladder cancer	3.84e-05	7.95e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—EP300—urinary bladder cancer	3.81e-05	7.89e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EGFR—urinary bladder cancer	3.75e-05	7.77e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS2—urinary bladder cancer	3.73e-05	7.73e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EP300—urinary bladder cancer	3.7e-05	7.68e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS2—urinary bladder cancer	3.63e-05	7.53e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SRC—urinary bladder cancer	3.6e-05	7.47e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—KRAS—urinary bladder cancer	3.54e-05	7.34e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTEN—urinary bladder cancer	3.25e-05	6.74e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—urinary bladder cancer	3.23e-05	6.69e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTEN—urinary bladder cancer	3.17e-05	6.57e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—EGFR—urinary bladder cancer	3.16e-05	6.54e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TP53—urinary bladder cancer	3.15e-05	6.53e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—EP300—urinary bladder cancer	3.1e-05	6.43e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—EP300—urinary bladder cancer	3.02e-05	6.27e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HRAS—urinary bladder cancer	3.01e-05	6.24e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—KRAS—urinary bladder cancer	2.98e-05	6.18e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—HRAS—urinary bladder cancer	2.54e-05	5.25e-05	CbGpPWpGaD
